Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byungsan Choi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|November 3, 2016
Observing Extremely Weak Protein-Protein Interactions with Conventional Single-Molecule Fluorescence MicroscopyJanghyun Yoo, Tae-Sun Lee, Byungsan Choi, et al.
Nature Protocols|September 28, 2013
Real-time single-molecule coimmunoprecipitation of weak protein-protein interactionsHong-Won Lee, Ji Young Ryu, Janghyun Yoo, et al.
Biomolecules|October 23, 2019
The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as PertuzumabJung Won Shin, Soohyun Kim, Suji Ha, et al.
Nature Biomedical Engineering|July 18, 2024
Profiling protein-protein interactions to predict the efficacy of B-cell-lymphoma-2-homology-3 mimetics for acute myeloid leukaemiaChangju Chun, Ja Min Byun, Minkwon Cha, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|November 3, 2016
Observing Extremely Weak Protein-Protein Interactions with Conventional Single-Molecule Fluorescence MicroscopyJanghyun Yoo, Tae-Sun Lee, Byungsan Choi, et al.
Nature Protocols|September 28, 2013
Real-time single-molecule coimmunoprecipitation of weak protein-protein interactionsHong-Won Lee, Ji Young Ryu, Janghyun Yoo, et al.
Biomolecules|October 23, 2019
The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as PertuzumabJung Won Shin, Soohyun Kim, Suji Ha, et al.
Nature Biomedical Engineering|July 18, 2024
Profiling protein-protein interactions to predict the efficacy of B-cell-lymphoma-2-homology-3 mimetics for acute myeloid leukaemiaChangju Chun, Ja Min Byun, Minkwon Cha, et al.
Pageof 1